Christina A Meadows1, Michael G Risbano1, Li Zhang1, Mark W Geraci1, Rubin M Tuder1, David H Collier2, Todd M Bull3. 1. Division of Pulmonary Sciences and Critical Care Medicine, University of Colorado Denver, Denver, CO. 2. Division of Rheumatology, Department of Medicine, University of Colorado Denver, Denver, CO. 3. Division of Pulmonary Sciences and Critical Care Medicine, University of Colorado Denver, Denver, CO. Electronic address: Todd.Bull@UCDenver.edu.
Abstract
BACKGROUND: Growth differentiation factor (GDF)-15 is a secreted member of the transforming growth factor-β cytokine superfamily. GDF-15 levels are elevated in the serum of patients with cardiovascular diseases. We hypothesized that GDF-15 levels would also be increased in the plasma and lung tissue of patients with systemic sclerosis-associated pulmonary arterial hypertension (SSc-PAH). METHODS: GDF-15 levels were measured in plasma in subjects with SSc-PAH (n = 30) and compared with subjects with systemic sclerosis (SSc) without pulmonary arterial hypertension (PAH) (n = 24). Patients with idiopathic PAH (IPAH) (n = 44) and normal individuals (n = 13) served as control subjects. Immunohistochemistry and immunofluorescence assay identified GDF-15 protein in lung tissue from patients with SSc-PAH and IPAH. RESULTS: Patients with SSc-PAH had significantly higher mean circulating levels of GDF-15 in plasma compared with patients with SSc without PAH (422.3 ± 369.5 pg/mL vs 108.1 ± 192.8 pg/mL, P = .004). GDF-15 levels correlated positively with estimated right ventricular systolic pressure on echocardiogram and plasma levels of the amino terminal propeptide form of brain natriuretic peptide. There was an inverse correlation between circulating GDF-15 and diffusing capacity of the lung for carbon monoxide (Dlco) and a positive correlation with the FVC to Dlco ratio on pulmonary function test. GDF-15 levels > 125 pg/mL were associated with reduced survival. GDF-15 protein expression was increased in lung tissue from patients with SSc-PAH. CONCLUSIONS: GDF-15 may be a useful biomarker in PAH associated with SSc. Its presence in lung tissue may suggest a role in the pathology of the disease.
BACKGROUND:Growth differentiation factor (GDF)-15 is a secreted member of the transforming growth factor-β cytokine superfamily. GDF-15 levels are elevated in the serum of patients with cardiovascular diseases. We hypothesized that GDF-15 levels would also be increased in the plasma and lung tissue of patients with systemic sclerosis-associated pulmonary arterial hypertension (SSc-PAH). METHODS:GDF-15 levels were measured in plasma in subjects with SSc-PAH (n = 30) and compared with subjects with systemic sclerosis (SSc) without pulmonary arterial hypertension (PAH) (n = 24). Patients with idiopathic PAH (IPAH) (n = 44) and normal individuals (n = 13) served as control subjects. Immunohistochemistry and immunofluorescence assay identified GDF-15 protein in lung tissue from patients with SSc-PAH and IPAH. RESULTS:Patients with SSc-PAH had significantly higher mean circulating levels of GDF-15 in plasma compared with patients with SSc without PAH (422.3 ± 369.5 pg/mL vs 108.1 ± 192.8 pg/mL, P = .004). GDF-15 levels correlated positively with estimated right ventricular systolic pressure on echocardiogram and plasma levels of the amino terminal propeptide form of brain natriuretic peptide. There was an inverse correlation between circulating GDF-15 and diffusing capacity of the lung for carbon monoxide (Dlco) and a positive correlation with the FVC to Dlco ratio on pulmonary function test. GDF-15 levels > 125 pg/mL were associated with reduced survival. GDF-15 protein expression was increased in lung tissue from patients with SSc-PAH. CONCLUSIONS:GDF-15 may be a useful biomarker in PAH associated with SSc. Its presence in lung tissue may suggest a role in the pathology of the disease.
Authors: Tibor Kempf; Matthias Eden; Jens Strelau; Marian Naguib; Christian Willenbockel; Jörn Tongers; Jörg Heineke; Daniel Kotlarz; Jian Xu; Jeffery D Molkentin; Hans W Niessen; Helmut Drexler; Kai C Wollert Journal: Circ Res Date: 2006-01-05 Impact factor: 17.367
Authors: Jian Xu; Thomas R Kimball; John N Lorenz; David A Brown; Asne R Bauskin; Raisa Klevitsky; Timothy E Hewett; Samuel N Breit; Jeffery D Molkentin Journal: Circ Res Date: 2006-01-05 Impact factor: 17.367
Authors: S C Mathai; M Bueso; L K Hummers; D Boyce; N Lechtzin; J Le Pavec; A Campo; H C Champion; T Housten; P R Forfia; A L Zaiman; F M Wigley; R E Girgis; P M Hassoun Journal: Eur Respir J Date: 2009-07-30 Impact factor: 16.671
Authors: A G Moore; D A Brown; W D Fairlie; A R Bauskin; P K Brown; M L Munier; P K Russell; L A Salamonsen; E M Wallace; S N Breit Journal: J Clin Endocrinol Metab Date: 2000-12 Impact factor: 5.958
Authors: L S Lonzetti; F Joyal; J P Raynauld; A Roussin; J R Goulet; E Rich; D Choquette; Y Raymond; J L Senécal Journal: Arthritis Rheum Date: 2001-03
Authors: Tibor Kempf; Stephan von Haehling; Timo Peter; Tim Allhoff; Mariantonietta Cicoira; Wolfram Doehner; Piotr Ponikowski; Gerasimos S Filippatos; Piotr Rozentryt; Helmut Drexler; Stefan D Anker; Kai C Wollert Journal: J Am Coll Cardiol Date: 2007-08-24 Impact factor: 24.094
Authors: Kai C Wollert; Tibor Kempf; Timo Peter; Sylvia Olofsson; Stefan James; Nina Johnston; Bertil Lindahl; Rüdiger Horn-Wichmann; Georg Brabant; Maarten L Simoons; Paul W Armstrong; Robert M Califf; Helmut Drexler; Lars Wallentin Journal: Circulation Date: 2007-02-05 Impact factor: 29.690
Authors: Fien M Verhamme; Christine M Freeman; Guy G Brusselle; Ken R Bracke; Jeffrey L Curtis Journal: Am J Respir Cell Mol Biol Date: 2019-06 Impact factor: 6.914
Authors: Nils Nickel; Danny Jonigk; Tibor Kempf; Clemens L Bockmeyer; Lavinia Maegel; Johanna Rische; Florian Laenger; Ulrich Lehmann; Clemens Sauer; Mark Greer; Tobias Welte; Marius M Hoeper; Heiko A Golpon Journal: Respir Res Date: 2011-05-06
Authors: Christine M Freeman; Carlos H Martinez; Jill C Todt; Fernando J Martinez; MeiLan K Han; Deborah L Thompson; Lisa McCloskey; Jeffrey L Curtis Journal: Respir Res Date: 2015-08-05
Authors: Brendan J Clark; Todd M Bull; Alexander B Benson; Amanda R Stream; Madison Macht; Jeanette Gaydos; Christina Meadows; Ellen L Burnham; Marc Moss Journal: Crit Care Date: 2013-05-24 Impact factor: 9.097